Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11884935rdf:typepubmed:Citationlld:pubmed
pubmed-article:11884935lifeskim:mentionsumls-concept:C0023911lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C0042172lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C0206754lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C0021212lld:lifeskim
pubmed-article:11884935lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:11884935pubmed:issue3lld:pubmed
pubmed-article:11884935pubmed:dateCreated2002-3-8lld:pubmed
pubmed-article:11884935pubmed:abstractTextPatients suffering from hepatic metastases of neuroendocrine tumors (NET) are potential candidates for orthotopic liver transplantation. Because recurrence rates are high and outcome is variable, prognostic indicators are required. The aim of our study was to identify predictors of long-term survival with a focus on the impact of tumor biology.lld:pubmed
pubmed-article:11884935pubmed:languageenglld:pubmed
pubmed-article:11884935pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11884935pubmed:citationSubsetIMlld:pubmed
pubmed-article:11884935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11884935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11884935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11884935pubmed:statusMEDLINElld:pubmed
pubmed-article:11884935pubmed:monthFeblld:pubmed
pubmed-article:11884935pubmed:issn0041-1337lld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:BoekerKlaus...lld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:MannsMichael...lld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:NashanBjörnBlld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:KlempnauerJür...lld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:SchmidtHartmu...lld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:LangHaukeHlld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:RosenauJensJlld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:BahrMatthias...lld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:11884935pubmed:authorpubmed-author:MengelMichael...lld:pubmed
pubmed-article:11884935pubmed:issnTypePrintlld:pubmed
pubmed-article:11884935pubmed:day15lld:pubmed
pubmed-article:11884935pubmed:volume73lld:pubmed
pubmed-article:11884935pubmed:ownerNLMlld:pubmed
pubmed-article:11884935pubmed:authorsCompleteYlld:pubmed
pubmed-article:11884935pubmed:pagination386-94lld:pubmed
pubmed-article:11884935pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:meshHeadingpubmed-meshheading:11884935...lld:pubmed
pubmed-article:11884935pubmed:year2002lld:pubmed
pubmed-article:11884935pubmed:articleTitleKi67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.lld:pubmed
pubmed-article:11884935pubmed:affiliationDepartment of Gastroenterology and Hepatology, Medical School of Hannover, 30171 Hannover, Germany.lld:pubmed
pubmed-article:11884935pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11884935lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11884935lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11884935lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11884935lld:pubmed